View ValuationThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsOrchid Ventures 将来の成長Future 基準チェック /06主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長31.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Sep 27+ 1 more updateOrchid Ventures, Inc. Announces Resignation of DirectorsOrchid Ventures, Inc. announced the resignation of its President, CFO and director, Richard Brown, and its independent director and Chair of the Audit Committee, Wayne Johnson. The Company announced the resignation of its CFO, President and Director, Richard Brown, effective immediately. The Company also announced the resignation of Director and Chair of the Audit Committee, Wayne Johnson, effective immediately. The Company wishes Mr. Brown and Mr. Johnson success in their future endeavors. Currently, Corey Mangold is the sole Director and Officer of the Company.お知らせ • Aug 05Orchid Ventures, Inc. announced that it has received CAD 0.074982 million in fundingOn August 4, 2022, Orchid Ventures, Inc. closed the transaction. The transaction included participation from single investor.お知らせ • Jul 24Orchid Ventures, Inc. Announces Executive ChangesOrchid Ventures Inc. announced it has removed Luke Hemphill as the Chief Product Officer. Luke Hemphill remains employed by the Company but is no longer in the Chief Product Officer position and is no longer an Officer of the Company effective July 1, 2022.Reported Earnings • May 10Third quarter 2022 earnings released: US$0.008 loss per share (vs US$0.039 loss in 3Q 2021)Third quarter 2022 results: US$0.008 loss per share (up from US$0.039 loss in 3Q 2021). Revenue: US$162.6k (down 74% from 3Q 2021). Net loss: US$381.9k (loss narrowed 58% from 3Q 2021).Board Change • Mar 08High number of new directorsIndependent Director Mervyn Simchowitz was the last director to join the board, commencing their role in 2021.Reported Earnings • Feb 13Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: US$0.009 loss per share (up from US$0.013 loss in 2Q 2021). Revenue: US$479.0k (down 44% from 2Q 2021). Net loss: US$413.8k (loss widened 46% from 2Q 2021). Revenue was in line with analyst estimates.Board Change • Jan 03High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Co-Founder, CEO & Chairman Corey Mangold is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Nov 05Full year 2021 earnings released: US$0.11 loss per share (vs US$0.30 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: US$3.72m (up 157% from FY 2020). Net loss: US$3.13m (loss narrowed 52% from FY 2020).お知らせ • Sep 10Orchid Ventures, Inc. Launches Proprietary New Technology Platform PurGuardOrchid Ventures, Inc. announces that the Company has launched it's proprietary new technology platform PurGuard, which it believes will have a significant impact on the usage of vape products by minors. Utilizing several key technologies and developing a proprietary software platform, the Company has developed an ecosystem for use in 510 thread cartridges and batteries, POD based systems, as well as disposable vaporizers. A consumer that purchases a PurGuard product, will have to verify their age through a web-based and/or mobile application that pairs with the device via Bluetooth or USB cable. The device also has an auto-lock feature that when the registered user of the device is not near the device, the device can auto-lock, eliminating the possibility of a minor using the device. This technological advancement is believed by the Company to be perhaps the biggest advancement in vaporizer safety technology in over a decade. With PurGuard products, a customer (brand) has the ability to "program" their cartridge, PODs or disposables with information from the lab reports such as brand, logo, strain name, potency, manufacture date and more. This allows users to know exactly what they are consuming when switching from cartridge to cartridge. PurGuard products will be available to cannabis and CBD companies worldwide by Winter 2021. These products will also be unveiled at MJ Biz Con in Las Vegas in mid October 2021.お知らせ • Jun 03Orchid Ventures, Inc. Announces Purtec Delivery Systems New R1 Technology Pass Emissions Testing with Flying ColorsOrchid Ventures, Inc. announced that the company has completed emissions testing with Enthalpy Analytical for their PurCore R1 510-thread cartridges and disposables. As seen in the reports (provided below), the products came back with flawless results containing no trace elements in the vapor tested against AFNOR standards, the strictest emissions standards set by the European Union. Tested compounds include Arsenic, Cadmium, Chromium, Lead, and Nickel. All PurTec products undergo the most stringent testing including emissions testing, leach testing, and dozens of manufacturing testing protocols to ensure the highest level of consumer safety. PurTec products are one of the only products on the market made entirely with FDA approved materials, ROHS and REACH standard compliant materials, and most importantly 316L medical-grade stainless steel in all heating elements. PurTec products are also free from glues and adhesives, and contain the highest quality ceramic available in vaporizers.Reported Earnings • May 30Third quarter 2021 earnings released: US$0.039 loss per share (vs US$0.013 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: US$619.6k (down 1.4% from 3Q 2020). Net loss: US$914.3k (loss widened 251% from 3Q 2020).お知らせ • Apr 03Orchid Ventures, Inc. announced that it has received CAD 4.2095 million in fundingOn April 1, 2021, Orchid Ventures, Inc. (CNSX:ORCD) closed the transaction. The company issued 16,838,000 units for gross proceeds of CAD 4,209,500. The company has paid eligible finders cash commission in the total amount of CAD 276,850 and also issued non-transferrable common share purchase warrants to the finders for the purchase of up to a total of 1,107,400 post consolidation shares. Each finder’s warrant will entitle the holder to purchase one post consolidation share at a price of CAD 0.25 on or before April 1, 2023.お知らせ • Apr 01Orchid Ventures, Inc. announced that it has received CAD 0.06313 million in fundingOn March 31, 2021, Orchid Ventures, Inc. (CNSX:ORCD) closed the transaction.お知らせ • Mar 04Orchid Ventures, Inc. announced that it expects to receive CAD 3.75 million in fundingOrchid Ventures, Inc. (CNSX:ORCD) announced a non-brokered private placement of up to 15,000,000 units at a price of CAD $0.25 per unit for gross proceeds of up to CAD 3,750,000 on March 3, 2021. Each Unit will consist of one post-consolidation share and one-half of one transferrable common share purchase warrant. Each warrant will entitle the holder to purchase one additional post-consolidation share at a price of $0.40 for a period of 24 months from the closing of the offering. The Company may pay a finder's fee within the amount permitted by the policies of the CSE. The closing of the offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the CSE. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.Reported Earnings • Mar 01Second quarter 2021 earnings released: US$0.003 loss per share (vs US$0.037 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$851.8k (up US$808.3k from 2Q 2020). Net loss: US$284.4k (loss narrowed 90% from 2Q 2020).Reported Earnings • Jan 23First quarter 2021 earnings released: EPS US$0.001The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$1.95m (up 137% from 1Q 2020). Net income: US$97.3k (up US$2.16m from 1Q 2020). Profit margin: 5.0% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue.お知らせ • Jan 17Orchid Ventures, Inc. Announces CFO ChangesOrchid Ventures, Inc. announced that in October 2020, Mathew Lee, the Chief Financial Officer tendered his resignation from the company, due to his desire to pursue other opportunities. His resignation was accepted and is effective January 15, 2021. The company has since filled the CFO role, having recently hired Yousuf Jaffar, FCA who is a Chartered Accountant with thirty years of post qualification experience in corporate finance. He has worked in senior positions in the manufacturing, telecommunication and real estate industries and has vast exposure to business environments in the US, Canada, Europe and Asia. Mr. Jaffar was appointed as CFO effective January 15, 2021.お知らせ • Nov 27Orchid Ventures Announces its Products Now Carried in Several New Key Retail AccountsOrchid Ventures, Inc. announced that it has launched its products into several new key retail accounts including SDRC in San Diego, High Times Delivery service, Sundial Collective and Redwood Herbal Alliance in Northern California and others. The company's continued sales growth initiatives with Landrace Distribution, Orchid's contract sales agency, have continued to expand into new key retail accounts and further the company's growth into the Northern California and Bay Area markets. Orchid is also set to launch its logistics and wholesale delivery efforts with Filigreen Distribution.お知らせ • Nov 18Orchid Ventures, Inc. Enters Sales and Distribution agreement with Landrace, LLCOrchid Ventures, Inc. announced the entering of a Sales and Distribution agreement with Landrace, LLC to handle all sales and field activities in the state of California. Orchid is excited to announce it has partnered with Landrace Distribution to handle all field sales support for the California market. The Landrace team is a highly experienced group of sales professionals with years of experience selling into the Cannabis marketplace.お知らせ • Oct 07Orchid Ventures, Inc. Announces Launch of New Product Lines for PurTec Delivery SystemsOrchid Ventures, Inc. announced that it’s hardware manufacturing subsidiary, PurTec Delivery Systems, has finalized development and testing on two new products; a disposable vape, and the most stringently tested value cartridge in the market. Both products have been through leach testing, which determines if any toxic materials or heavy metals leach into the oil put into the cart, as well as PurTec’s industry leading AFNOR standards emissions testing. An emissions test evaluates the actual vapor exiting the hardware, which is what consumers inhale.お知らせ • Sep 24Orchid Ventures, Inc. Announces Launch of Three New Product Lines and Expanded Inventory ProductionORCHID VENTURES, INC. announced that it is launching three new product lines in California and Oregon. The Orchid Brands team has been hard at work developing three news lines of vape products as the company has seen a complete rebound in vape sales since the vape scare of 2019. These products have been developed and will be positioned to appeal to different consumer segments. Firstly, there is Orchid Vibes, a value-priced product featuring a newly developed PurTec Summit cartridge and introducing more contemporary terpene profiles like Mimosa and Purple Punch. The company has also improved the Orchid Classic line up, which are mid-tier products featuring their classic Orchid Essential formulations like Jack Herer and Dutch Treat among many other terpene profiles, all available in their best-in-class Orchid hardware. Lastly, the company is introducing Orchid Gold, live resin seasonal craft strains and flavors that rotate throughout the year and are also available in their top-tier Orchid hardware. The new product lines are currently being launched into the Oregon market through an Orchid Licensee, Tine Trading Company, and in California through partnerships with contract manufacturers and the company’s evolving distribution network. Orchid California and Orchid Oregon now have produced in the last 30 days more inventory than any other single month in the previous twelve (12) months. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Orchid Ventures は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測CNSX:ORCD - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/20221-3-3-3N/A12/31/20212-4-3-3N/A9/30/20212-3-2-2N/A6/30/20214-3-2-2N/A3/31/20213-311N/A12/31/20204-210N/A9/30/20203-400N/A6/30/20201-7-1-1N/A2/29/20204-10-4-4N/A11/30/20195-11-5-5N/A8/31/20195-9-6-6N/A5/31/20196-7-6-6N/A2/28/20194-2-3-3N/A11/30/20183-2-2-2N/A8/31/20183-1-10N/A5/31/20182-2-1-1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ORCDの予測収益成長が 貯蓄率 ( 1.7% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: ORCDの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: ORCDの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: ORCDの収益がCanadian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: ORCDの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ORCDの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/01/31 17:01終値2022/11/04 00:00収益2022/03/31年間収益2021/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Orchid Ventures, Inc. これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Sep 27+ 1 more updateOrchid Ventures, Inc. Announces Resignation of DirectorsOrchid Ventures, Inc. announced the resignation of its President, CFO and director, Richard Brown, and its independent director and Chair of the Audit Committee, Wayne Johnson. The Company announced the resignation of its CFO, President and Director, Richard Brown, effective immediately. The Company also announced the resignation of Director and Chair of the Audit Committee, Wayne Johnson, effective immediately. The Company wishes Mr. Brown and Mr. Johnson success in their future endeavors. Currently, Corey Mangold is the sole Director and Officer of the Company.
お知らせ • Aug 05Orchid Ventures, Inc. announced that it has received CAD 0.074982 million in fundingOn August 4, 2022, Orchid Ventures, Inc. closed the transaction. The transaction included participation from single investor.
お知らせ • Jul 24Orchid Ventures, Inc. Announces Executive ChangesOrchid Ventures Inc. announced it has removed Luke Hemphill as the Chief Product Officer. Luke Hemphill remains employed by the Company but is no longer in the Chief Product Officer position and is no longer an Officer of the Company effective July 1, 2022.
Reported Earnings • May 10Third quarter 2022 earnings released: US$0.008 loss per share (vs US$0.039 loss in 3Q 2021)Third quarter 2022 results: US$0.008 loss per share (up from US$0.039 loss in 3Q 2021). Revenue: US$162.6k (down 74% from 3Q 2021). Net loss: US$381.9k (loss narrowed 58% from 3Q 2021).
Board Change • Mar 08High number of new directorsIndependent Director Mervyn Simchowitz was the last director to join the board, commencing their role in 2021.
Reported Earnings • Feb 13Second quarter 2022 earnings: Revenues and EPS in line with analyst expectationsSecond quarter 2022 results: US$0.009 loss per share (up from US$0.013 loss in 2Q 2021). Revenue: US$479.0k (down 44% from 2Q 2021). Net loss: US$413.8k (loss widened 46% from 2Q 2021). Revenue was in line with analyst estimates.
Board Change • Jan 03High number of new and inexperienced directorsThere are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. No highly experienced directors. Co-Founder, CEO & Chairman Corey Mangold is the most experienced director on the board, commencing their role in 2019. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Nov 05Full year 2021 earnings released: US$0.11 loss per share (vs US$0.30 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: US$3.72m (up 157% from FY 2020). Net loss: US$3.13m (loss narrowed 52% from FY 2020).
お知らせ • Sep 10Orchid Ventures, Inc. Launches Proprietary New Technology Platform PurGuardOrchid Ventures, Inc. announces that the Company has launched it's proprietary new technology platform PurGuard, which it believes will have a significant impact on the usage of vape products by minors. Utilizing several key technologies and developing a proprietary software platform, the Company has developed an ecosystem for use in 510 thread cartridges and batteries, POD based systems, as well as disposable vaporizers. A consumer that purchases a PurGuard product, will have to verify their age through a web-based and/or mobile application that pairs with the device via Bluetooth or USB cable. The device also has an auto-lock feature that when the registered user of the device is not near the device, the device can auto-lock, eliminating the possibility of a minor using the device. This technological advancement is believed by the Company to be perhaps the biggest advancement in vaporizer safety technology in over a decade. With PurGuard products, a customer (brand) has the ability to "program" their cartridge, PODs or disposables with information from the lab reports such as brand, logo, strain name, potency, manufacture date and more. This allows users to know exactly what they are consuming when switching from cartridge to cartridge. PurGuard products will be available to cannabis and CBD companies worldwide by Winter 2021. These products will also be unveiled at MJ Biz Con in Las Vegas in mid October 2021.
お知らせ • Jun 03Orchid Ventures, Inc. Announces Purtec Delivery Systems New R1 Technology Pass Emissions Testing with Flying ColorsOrchid Ventures, Inc. announced that the company has completed emissions testing with Enthalpy Analytical for their PurCore R1 510-thread cartridges and disposables. As seen in the reports (provided below), the products came back with flawless results containing no trace elements in the vapor tested against AFNOR standards, the strictest emissions standards set by the European Union. Tested compounds include Arsenic, Cadmium, Chromium, Lead, and Nickel. All PurTec products undergo the most stringent testing including emissions testing, leach testing, and dozens of manufacturing testing protocols to ensure the highest level of consumer safety. PurTec products are one of the only products on the market made entirely with FDA approved materials, ROHS and REACH standard compliant materials, and most importantly 316L medical-grade stainless steel in all heating elements. PurTec products are also free from glues and adhesives, and contain the highest quality ceramic available in vaporizers.
Reported Earnings • May 30Third quarter 2021 earnings released: US$0.039 loss per share (vs US$0.013 loss in 3Q 2020)The company reported a poor third quarter result with increased losses, weaker revenues and weaker control over costs. Third quarter 2021 results: Revenue: US$619.6k (down 1.4% from 3Q 2020). Net loss: US$914.3k (loss widened 251% from 3Q 2020).
お知らせ • Apr 03Orchid Ventures, Inc. announced that it has received CAD 4.2095 million in fundingOn April 1, 2021, Orchid Ventures, Inc. (CNSX:ORCD) closed the transaction. The company issued 16,838,000 units for gross proceeds of CAD 4,209,500. The company has paid eligible finders cash commission in the total amount of CAD 276,850 and also issued non-transferrable common share purchase warrants to the finders for the purchase of up to a total of 1,107,400 post consolidation shares. Each finder’s warrant will entitle the holder to purchase one post consolidation share at a price of CAD 0.25 on or before April 1, 2023.
お知らせ • Apr 01Orchid Ventures, Inc. announced that it has received CAD 0.06313 million in fundingOn March 31, 2021, Orchid Ventures, Inc. (CNSX:ORCD) closed the transaction.
お知らせ • Mar 04Orchid Ventures, Inc. announced that it expects to receive CAD 3.75 million in fundingOrchid Ventures, Inc. (CNSX:ORCD) announced a non-brokered private placement of up to 15,000,000 units at a price of CAD $0.25 per unit for gross proceeds of up to CAD 3,750,000 on March 3, 2021. Each Unit will consist of one post-consolidation share and one-half of one transferrable common share purchase warrant. Each warrant will entitle the holder to purchase one additional post-consolidation share at a price of $0.40 for a period of 24 months from the closing of the offering. The Company may pay a finder's fee within the amount permitted by the policies of the CSE. The closing of the offering is subject to a number of conditions, including receipt of all necessary corporate and regulatory approvals, including the CSE. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.
Reported Earnings • Mar 01Second quarter 2021 earnings released: US$0.003 loss per share (vs US$0.037 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: US$851.8k (up US$808.3k from 2Q 2020). Net loss: US$284.4k (loss narrowed 90% from 2Q 2020).
Reported Earnings • Jan 23First quarter 2021 earnings released: EPS US$0.001The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$1.95m (up 137% from 1Q 2020). Net income: US$97.3k (up US$2.16m from 1Q 2020). Profit margin: 5.0% (up from net loss in 1Q 2020). The move to profitability was primarily driven by higher revenue.
お知らせ • Jan 17Orchid Ventures, Inc. Announces CFO ChangesOrchid Ventures, Inc. announced that in October 2020, Mathew Lee, the Chief Financial Officer tendered his resignation from the company, due to his desire to pursue other opportunities. His resignation was accepted and is effective January 15, 2021. The company has since filled the CFO role, having recently hired Yousuf Jaffar, FCA who is a Chartered Accountant with thirty years of post qualification experience in corporate finance. He has worked in senior positions in the manufacturing, telecommunication and real estate industries and has vast exposure to business environments in the US, Canada, Europe and Asia. Mr. Jaffar was appointed as CFO effective January 15, 2021.
お知らせ • Nov 27Orchid Ventures Announces its Products Now Carried in Several New Key Retail AccountsOrchid Ventures, Inc. announced that it has launched its products into several new key retail accounts including SDRC in San Diego, High Times Delivery service, Sundial Collective and Redwood Herbal Alliance in Northern California and others. The company's continued sales growth initiatives with Landrace Distribution, Orchid's contract sales agency, have continued to expand into new key retail accounts and further the company's growth into the Northern California and Bay Area markets. Orchid is also set to launch its logistics and wholesale delivery efforts with Filigreen Distribution.
お知らせ • Nov 18Orchid Ventures, Inc. Enters Sales and Distribution agreement with Landrace, LLCOrchid Ventures, Inc. announced the entering of a Sales and Distribution agreement with Landrace, LLC to handle all sales and field activities in the state of California. Orchid is excited to announce it has partnered with Landrace Distribution to handle all field sales support for the California market. The Landrace team is a highly experienced group of sales professionals with years of experience selling into the Cannabis marketplace.
お知らせ • Oct 07Orchid Ventures, Inc. Announces Launch of New Product Lines for PurTec Delivery SystemsOrchid Ventures, Inc. announced that it’s hardware manufacturing subsidiary, PurTec Delivery Systems, has finalized development and testing on two new products; a disposable vape, and the most stringently tested value cartridge in the market. Both products have been through leach testing, which determines if any toxic materials or heavy metals leach into the oil put into the cart, as well as PurTec’s industry leading AFNOR standards emissions testing. An emissions test evaluates the actual vapor exiting the hardware, which is what consumers inhale.
お知らせ • Sep 24Orchid Ventures, Inc. Announces Launch of Three New Product Lines and Expanded Inventory ProductionORCHID VENTURES, INC. announced that it is launching three new product lines in California and Oregon. The Orchid Brands team has been hard at work developing three news lines of vape products as the company has seen a complete rebound in vape sales since the vape scare of 2019. These products have been developed and will be positioned to appeal to different consumer segments. Firstly, there is Orchid Vibes, a value-priced product featuring a newly developed PurTec Summit cartridge and introducing more contemporary terpene profiles like Mimosa and Purple Punch. The company has also improved the Orchid Classic line up, which are mid-tier products featuring their classic Orchid Essential formulations like Jack Herer and Dutch Treat among many other terpene profiles, all available in their best-in-class Orchid hardware. Lastly, the company is introducing Orchid Gold, live resin seasonal craft strains and flavors that rotate throughout the year and are also available in their top-tier Orchid hardware. The new product lines are currently being launched into the Oregon market through an Orchid Licensee, Tine Trading Company, and in California through partnerships with contract manufacturers and the company’s evolving distribution network. Orchid California and Orchid Oregon now have produced in the last 30 days more inventory than any other single month in the previous twelve (12) months.